ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Gene Therapy for X-Linked Retinitis Pigmentosa"
Episode Synopsis
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.
More episodes of the podcast Retina Synthesis
Stem Cell Therapy for Geographic Atrophy
19/11/2025
8 mg Aflibercept in Diabetic Macular Edema
08/10/2025
In God we trust